Lv25
200 积分 2025-03-12 加入
Impact of ICH Q11 Questions and Answers on the Outcome of Active Pharmaceutical Ingredient Starting Material Proposal Acceptance by ICH Regulatory Members
4天前
已完结
A Consideration of the Extent That Tertiary Amines Can Form N-Nitroso Dialkylamines in Pharmaceutical Products
17天前
已完结
Application of an Interdisciplinary Approach to Form Selection in Drug Development
17天前
已完结
Advancing Peptide Synthesis: Liquid-Phase Assembly of Tirzepatide’s C-Terminus (30–39) via Crystalline Pentamer Building Blocks
18天前
已完结
Process Development of the Novel LpxC Inhibitor T-1228. Part 1: Synthesis of the Diol Fragment
18天前
已完结
Application of Direct Inject Liquid Chromatography (DILC) as Real-Time Process Analytical Technology for Flow Reactions
18天前
已完结
Process Development of the Novel LpxC Inhibitor T-1228. Part 2: Synthesis of the Malonamide Core and the Final Intermediate
18天前
已完结
A Sustainable Approach to ε-Lys Branched GLP-1 Analogs: Integrating Green SPPS, Metal-free Alloc Removal, Waste Minimization and TFA/PFAS-free Resin Cleavage
18天前
已完结
Process Development of the Novel LpxC Inhibitor T-1228: Part 3: Optimization of the Deprotection Reaction and the Crystallization for the Final Step of API Synthesis
18天前
已完结
Identification of Tamsulosin-Dimeric Impurity, Leading to the Efficient Manufacturing Process of the Active Pharmaceutical Ingredient
18天前
已完结
皖公网安备34019202002308
